DNLI: Denali Therapeutics Inc. Stock

by  •  • Comments Off on DNLI: Denali Therapeutics Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 2,444.55
Enterprise Value ($M) 2,317.45
Book Value ($M) 1,030.95
Book Value / Share 7.23
Price / Book 2.37
NCAV ($M) 941.17
NCAV / Share 6.60
Price / NCAV 2.60

Profitability (mra)
Return on Invested Capital (ROIC) -0.13
Return on Assets (ROA) -0.10
Return on Equity (ROE) -0.15

Liquidity (mrq)
Quick Ratio 13.65
Current Ratio 13.65

Balance Sheet (mrq) ($M)
Current Assets 1,064.14
Assets 1,153.92
Liabilities 122.96
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 330.53
Operating Income -196.70
Net Income -145.22
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -357.99
Cash from Investing 249.31
Cash from Financing 17.82

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Bratton Douglas K 4.20 -17.85
02-13 13G/A Vanguard Group Inc 7.84 8.92
02-12 13G/A Biogen Inc. 9.23 -4.20
02-08 13G Wellington Management Group Llp 5.26
01-30 13G/A Temasek Holdings (Private) Ltd 4.90 0.00
01-30 13G/A Baillie Gifford & Co 10.32 -5.68
01-25 13G/A BlackRock Inc. 8.40 23.83

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-06 66,752 383,599 17.40
2024-05-03 135,565 868,040 15.62
2024-05-02 135,824 397,369 34.18
2024-05-01 136,912 739,236 18.52

(click for more detail)

Similar Companies
CYTK – Cytokinetics, Incorporated DAWN – Day One Biopharmaceuticals, Inc.
DCPH – Deciphera Pharmaceuticals, Inc. DSGN – Design Therapeutics, Inc.
DVAX – Dynavax Technologies Corporation


Financial data and stock pages provided by
Fintel.io